Past year
All results
- All results
- Verbatim
Sep 17, 2024 · In the US, Kisqali is indicated for the treatment of adults with HR+/HER2- advanced or MBC in combination with an AI as initial ET or fulvestrant as initial ...
5 days ago · Kisqali has been approved as a treatment for breast cancer by regulatory authorities in more than 100 countries worldwide, including the U.S. FDA and the ...
Oct 10, 2024 · FDA approves inavolisib with palbociclib and fulvestrant for endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative, advanced breast cancer · Share ...
Missing: kisqali | Show results with:kisqali
May 29, 2024 · Kisqali (succinato de ribociclibe) é utilizado em pacientes que possuem um tipo de câncer de mama chamado de câncer de mama receptor hormonal positivo (RH+), e ...
R$13,195.43
Dec 13, 2023 · Indicação de Bula: Tratamento de Câncer de mama receptor hormonal positivo. Produto refrigerado? Não, temperatura ambiente entre 15 e 30 graus. Tipo de ...
Aug 6, 2024 · Segundo a bula do medicamento2 aprovada pela ANVISA, “Kisqali (succinato de ribociclibe) é indicado para o tratamento de pacientes, com câncer de mama ...
Nov 15, 2024 · Pyzchiva® is approved for treatment of adults with plaque psoriasis, psoriatic arthritis, Crohn's disease and pediatric plaque psoriasis for patients six years ...
Aug 2, 2024 · Trade Name: Kisqali. Rifabutin. Drug class: Antibacterials. Trade Name: Mycobutin. Rifampicin (Rifampin). Drug class: Antibacterials. Trade Name: Rifadin ...
Missing: bula | Show results with:bula
May 10, 2024 · PACIENTE. 1.1. Nome: S.N.A. 1.2. Data de nascimento: 22/05/1988. 1.3. Sexo: Feminino. 1.4. Diagnóstico: Câncer de mama metastático para osso (CID10: C50).